# A Trial in Subjects Suspected to Have Tuberculosis, Comparing the Diagnostic Performance of C-Tb to QuantiFERON®, in Combination With a Safety Assessment of C-Tb Versus Tuberculin PPD RT23 SSI

> **NCT01642888** · PHASE3 · COMPLETED · sponsor: **Statens Serum Institut** · enrollment: 1190 (actual)

## Conditions studied

- Tuberculosis

## Interventions

- **BIOLOGICAL:** C-Tb
- **BIOLOGICAL:** 2 T.U. Tuberculin PPD RT 23 SSI

## Key facts

- **NCT ID:** NCT01642888
- **Lead sponsor:** Statens Serum Institut
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 1190 (ACTUAL)
- **Last updated:** 2016-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01642888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01642888, "A Trial in Subjects Suspected to Have Tuberculosis, Comparing the Diagnostic Performance of C-Tb to QuantiFERON®, in Combination With a Safety Assessment of C-Tb Versus Tuberculin PPD RT23 SSI". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01642888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*